Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May-Jun;9(3):224-228.
doi: 10.4103/idoj.IDOJ_62_16.

Bimatoprost in Dermatology

Abhijeet K Jha  1 , Rashmi Sarkar  2 , Uday K Udayan  1 , P K Roy  1 , Amar K Jha  1 , R K P Chaudhary  1
Affiliations

Bimatoprost in Dermatology

Abhijeet K Jha et al. Indian Dermatol Online J. 2018 May-Jun.

Abstract

Bimatoprost is a prostamide analogue used for treatment of glaucoma in ophthalmology. Surprisingly, the side effects such as increased pigmentation of eyelids and hypertrichosis in patients being treated with prostaglandin analogues for glaucoma have opened new areas of application in various dermatological disorders such as alopecia mainly affecting eyelashes, eyebrows, and vitiligo.

Keywords: Alopecia areata; bimatoprost; vitiligo.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Comment in

References

    1. Woodward DF, Liang Y, Krauss AH-P. Prostamides (prostaglandin- ethanolamides) and their pharmacology. Br J Pharmacol. 2008;153:410–9. - PMC - PubMed
    1. Smyth EM, Burke A, FitzGerald GA. Lipid-derived autacoids: Eicosanoids and platelet-activating factor. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gillman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2005. pp. 653–70.
    1. Woodward DF, Krauss AH-P, Chen J, Lai RK, Spada CS, Burk RM, et al. The pharmacology of bimatoprost (Lumigant) Surv Ophthalmol. 2001;45:S337–45. - PubMed
    1. Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: Areview of recent studies of two new glaucoma drugs. Surv Ophthalmol. 2002;47:S105–15. - PubMed
    1. Woodward DF, Carling RW, Cornell C.L, Fliri HG, Martos JL, Pettit SN, et al. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol Ther. 2008;120:71–80. - PubMed